Myriad Genetics: Q2 Earnings Insights

Myriad Genetics MYGN reported its Q2 earnings results on Thursday, August 4, 2022 at 07:05 AM.

Here's what investors need to know about the announcement.

Earnings

Myriad Genetics beat estimated earnings by 300.0%, reporting an EPS of $0.04 versus an estimate of $0.01.

Revenue was down $10.10 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 0.6% drop in the share price the next day.

Here's a look at Myriad Genetics's past performance:

To track all earnings releases for Myriad Genetics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.